Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis

Silvia Bruno, Marina Fabbi, Micaela Tiso, Barbara Santamaria, Fabio Ghiotto, Daniele Saverino, Claudya Tenca, Daniela Zarcone, Silvano Ferrini, Ermanno Ciccone, Carlo E. Grossi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Squamous cell carcinoma (SCC) derives from dysplastic or metaplastic stratified epithelia. The process of squamous cell carcinogenesis has been investigated for the potential role of the adhesion molecule CD44, whose standard form (CD44s) and isoforms generated by alternative splicing of variant exons are known to display altered expression during tumorigenesis in other systems. We have utilized an in vitro correlate of squamous cell carcinogenesis, in which progression stages from normal squamous epithelium to dysplastic lesions and to SCC are represented by primary cultures of normal keratinocytes, by human papilloma virus-immortalized keratinocytes (UP) and by HPV-immortalized/v-Ha-ras transfected tumorigenic keratinocytes (UPR). We investigated expression of CD44 and of variant isoforms, from mRNA to intracellular and surface protein levels, and found no relationship between expression of CD44 and stages of squamous cell carcinogenesis. However, when the function of CD44 was analyzed as Ca2+ mobilization ability upon monoclonal antibody binding and crosslinking, signal transduction via CD44 was found only for the neoplastic stage (UPR cells). Ca2+ mobilization was completely independent of density of surface CD44. We have performed similar analyses in an in vitro model of SCC in which four squamous tumor cell lines and UPR cells were sorted according to increasing resistance to external cytotoxic stimuli, i.e. starving conditions, treatment with the retinoid N-(4-hydroxyphenyl)retinamide and cytolytic activity of effector lymphokine-activated killer cells. No relationship between expression of CD44 and level of cell resistance against external cell death-inducing stimuli was found, while CD44-mediated Ca2+ mobilization ability was restricted to the highly resistant tumor cell lines. Our results indicate that the role(s) of CD44 in squamous cell proliferative disorders can be evinced from the functional features of the molecule, rather than from its phenotypic repertoire.

Original languageEnglish
Pages (from-to)893-900
Number of pages8
JournalCarcinogenesis
Volume21
Issue number5
Publication statusPublished - 2000

Fingerprint

Carcinogenesis
Epithelial Cells
Keratinocytes
Squamous Cell Carcinoma
Tumor Cell Line
Papillomaviridae
Epithelium
Fenretinide
RNA Isoforms
Lymphokine-Activated Killer Cells
Retinoids
Alternative Splicing
Exons
Signal Transduction
Protein Isoforms
Membrane Proteins
Cell Death
Monoclonal Antibodies
In Vitro Techniques

ASJC Scopus subject areas

  • Cancer Research

Cite this

Bruno, S., Fabbi, M., Tiso, M., Santamaria, B., Ghiotto, F., Saverino, D., ... Grossi, C. E. (2000). Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis. Carcinogenesis, 21(5), 893-900.

Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis. / Bruno, Silvia; Fabbi, Marina; Tiso, Micaela; Santamaria, Barbara; Ghiotto, Fabio; Saverino, Daniele; Tenca, Claudya; Zarcone, Daniela; Ferrini, Silvano; Ciccone, Ermanno; Grossi, Carlo E.

In: Carcinogenesis, Vol. 21, No. 5, 2000, p. 893-900.

Research output: Contribution to journalArticle

Bruno, S, Fabbi, M, Tiso, M, Santamaria, B, Ghiotto, F, Saverino, D, Tenca, C, Zarcone, D, Ferrini, S, Ciccone, E & Grossi, CE 2000, 'Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis', Carcinogenesis, vol. 21, no. 5, pp. 893-900.
Bruno S, Fabbi M, Tiso M, Santamaria B, Ghiotto F, Saverino D et al. Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis. Carcinogenesis. 2000;21(5):893-900.
Bruno, Silvia ; Fabbi, Marina ; Tiso, Micaela ; Santamaria, Barbara ; Ghiotto, Fabio ; Saverino, Daniele ; Tenca, Claudya ; Zarcone, Daniela ; Ferrini, Silvano ; Ciccone, Ermanno ; Grossi, Carlo E. / Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis. In: Carcinogenesis. 2000 ; Vol. 21, No. 5. pp. 893-900.
@article{57825deb9b8746f7bb4e5da2f0393cc8,
title = "Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis",
abstract = "Squamous cell carcinoma (SCC) derives from dysplastic or metaplastic stratified epithelia. The process of squamous cell carcinogenesis has been investigated for the potential role of the adhesion molecule CD44, whose standard form (CD44s) and isoforms generated by alternative splicing of variant exons are known to display altered expression during tumorigenesis in other systems. We have utilized an in vitro correlate of squamous cell carcinogenesis, in which progression stages from normal squamous epithelium to dysplastic lesions and to SCC are represented by primary cultures of normal keratinocytes, by human papilloma virus-immortalized keratinocytes (UP) and by HPV-immortalized/v-Ha-ras transfected tumorigenic keratinocytes (UPR). We investigated expression of CD44 and of variant isoforms, from mRNA to intracellular and surface protein levels, and found no relationship between expression of CD44 and stages of squamous cell carcinogenesis. However, when the function of CD44 was analyzed as Ca2+ mobilization ability upon monoclonal antibody binding and crosslinking, signal transduction via CD44 was found only for the neoplastic stage (UPR cells). Ca2+ mobilization was completely independent of density of surface CD44. We have performed similar analyses in an in vitro model of SCC in which four squamous tumor cell lines and UPR cells were sorted according to increasing resistance to external cytotoxic stimuli, i.e. starving conditions, treatment with the retinoid N-(4-hydroxyphenyl)retinamide and cytolytic activity of effector lymphokine-activated killer cells. No relationship between expression of CD44 and level of cell resistance against external cell death-inducing stimuli was found, while CD44-mediated Ca2+ mobilization ability was restricted to the highly resistant tumor cell lines. Our results indicate that the role(s) of CD44 in squamous cell proliferative disorders can be evinced from the functional features of the molecule, rather than from its phenotypic repertoire.",
author = "Silvia Bruno and Marina Fabbi and Micaela Tiso and Barbara Santamaria and Fabio Ghiotto and Daniele Saverino and Claudya Tenca and Daniela Zarcone and Silvano Ferrini and Ermanno Ciccone and Grossi, {Carlo E.}",
year = "2000",
language = "English",
volume = "21",
pages = "893--900",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis

AU - Bruno, Silvia

AU - Fabbi, Marina

AU - Tiso, Micaela

AU - Santamaria, Barbara

AU - Ghiotto, Fabio

AU - Saverino, Daniele

AU - Tenca, Claudya

AU - Zarcone, Daniela

AU - Ferrini, Silvano

AU - Ciccone, Ermanno

AU - Grossi, Carlo E.

PY - 2000

Y1 - 2000

N2 - Squamous cell carcinoma (SCC) derives from dysplastic or metaplastic stratified epithelia. The process of squamous cell carcinogenesis has been investigated for the potential role of the adhesion molecule CD44, whose standard form (CD44s) and isoforms generated by alternative splicing of variant exons are known to display altered expression during tumorigenesis in other systems. We have utilized an in vitro correlate of squamous cell carcinogenesis, in which progression stages from normal squamous epithelium to dysplastic lesions and to SCC are represented by primary cultures of normal keratinocytes, by human papilloma virus-immortalized keratinocytes (UP) and by HPV-immortalized/v-Ha-ras transfected tumorigenic keratinocytes (UPR). We investigated expression of CD44 and of variant isoforms, from mRNA to intracellular and surface protein levels, and found no relationship between expression of CD44 and stages of squamous cell carcinogenesis. However, when the function of CD44 was analyzed as Ca2+ mobilization ability upon monoclonal antibody binding and crosslinking, signal transduction via CD44 was found only for the neoplastic stage (UPR cells). Ca2+ mobilization was completely independent of density of surface CD44. We have performed similar analyses in an in vitro model of SCC in which four squamous tumor cell lines and UPR cells were sorted according to increasing resistance to external cytotoxic stimuli, i.e. starving conditions, treatment with the retinoid N-(4-hydroxyphenyl)retinamide and cytolytic activity of effector lymphokine-activated killer cells. No relationship between expression of CD44 and level of cell resistance against external cell death-inducing stimuli was found, while CD44-mediated Ca2+ mobilization ability was restricted to the highly resistant tumor cell lines. Our results indicate that the role(s) of CD44 in squamous cell proliferative disorders can be evinced from the functional features of the molecule, rather than from its phenotypic repertoire.

AB - Squamous cell carcinoma (SCC) derives from dysplastic or metaplastic stratified epithelia. The process of squamous cell carcinogenesis has been investigated for the potential role of the adhesion molecule CD44, whose standard form (CD44s) and isoforms generated by alternative splicing of variant exons are known to display altered expression during tumorigenesis in other systems. We have utilized an in vitro correlate of squamous cell carcinogenesis, in which progression stages from normal squamous epithelium to dysplastic lesions and to SCC are represented by primary cultures of normal keratinocytes, by human papilloma virus-immortalized keratinocytes (UP) and by HPV-immortalized/v-Ha-ras transfected tumorigenic keratinocytes (UPR). We investigated expression of CD44 and of variant isoforms, from mRNA to intracellular and surface protein levels, and found no relationship between expression of CD44 and stages of squamous cell carcinogenesis. However, when the function of CD44 was analyzed as Ca2+ mobilization ability upon monoclonal antibody binding and crosslinking, signal transduction via CD44 was found only for the neoplastic stage (UPR cells). Ca2+ mobilization was completely independent of density of surface CD44. We have performed similar analyses in an in vitro model of SCC in which four squamous tumor cell lines and UPR cells were sorted according to increasing resistance to external cytotoxic stimuli, i.e. starving conditions, treatment with the retinoid N-(4-hydroxyphenyl)retinamide and cytolytic activity of effector lymphokine-activated killer cells. No relationship between expression of CD44 and level of cell resistance against external cell death-inducing stimuli was found, while CD44-mediated Ca2+ mobilization ability was restricted to the highly resistant tumor cell lines. Our results indicate that the role(s) of CD44 in squamous cell proliferative disorders can be evinced from the functional features of the molecule, rather than from its phenotypic repertoire.

UR - http://www.scopus.com/inward/record.url?scp=0034020638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034020638&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 893

EP - 900

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 5

ER -